COMMERCIAL TIMES in Taiwan reports Firstohm's investment in a genetic engineering firm Symbigene Inc.　

(2004-Mar-06)

　

　A renowned press firm COMMERCIAL TIMES in Taiwan reports Firstohm's direct investment in Symbigene Inc, which acquired substantial progress in the research pipeline of 4th-generation monoclonal antibody and genetic alteration of acidophilus or yeast to be a medicine carrier.

　

News Clip

　

<<BACK

FIRST RESISTOR & CONDENSER CO., LTD.
TEL:+886-2-2705-1878 +886-2-2707-9869 FAX:+886-2-2703-6701 

Copyright 2000 by First Resistor & Condenser Co., Ltd.
All rights reserved. Reproduction of site contents in whole or in part or
in any form for any commercial purpose without express written permission
of First Resistor & Condenser Co., Ltd is prohibited..